Previous close | 14.08 |
Open | 14.15 |
Bid | 14.00 x 3100 |
Ask | 14.01 x 4000 |
Day's range | 13.97 - 14.16 |
52-week range | 7.09 - 14.47 |
Volume | |
Avg. volume | 9,274,459 |
Market cap | 15.834B |
Beta (5Y monthly) | 1.06 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 27 Nov 2017 |
1y target est | N/A |
Evaluate the expected performance of Teva Pharmaceutical Industries (TEVA) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2024 Earnings Call Transcript May 1, 2024 Corcept Therapeutics Incorporated beats earnings expectations. Reported EPS is $0.2503, expectations were $0.21. Corcept Therapeutics Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank […]
Q1 2024 Corcept Therapeutics Inc Earnings Call